Product image of Igantet (Human Tetanus Immunoglobulin) supplied by GNH India

Igantet

Active Ingredient:
Human Tetanus Immunoglobulin
Origin:
EU

Igantet (Human Tetanus Immunoglobulin)

Human Tetanus Immunoglobulin, the active ingredient in Igantet, is a human immunoglobulin presented as an injection solution for intramuscular administration. It supplies anti‑tetanus antibodies that neutralize tetanus toxin, providing passive immunity for individuals at risk of tetanus and for patients with established tetanus infection.

GNH India supplies Igantet as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide in accordance with EU quality standards. The company ensures appropriate cold‑chain storage and regulatory compliance for each shipment.

Manufacturer / TM Owner

Instituto Grifols, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Igantet, a human tetanus immunoglobulin, is used within the tetanus immune globulin class for passive immunization against tetanus toxin.

  • Prophylaxis of tetanus: Provides immediate protection for individuals with uncertain vaccination status or with dirty wounds.
  • Treatment of tetanus infection: Supplies antibodies to neutralize toxin in patients diagnosed with tetanus.
  • Post‑exposure management: Administered after injuries that pose a high risk of tetanus when active immunization is insufficient.

How It Works

  • Human tetanus immunoglobulin consists of purified IgG antibodies that specifically bind to tetanus neurotoxin. By forming immune complexes, the antibodies prevent the toxin from attaching to neuronal receptors and block its internalization, thereby neutralizing its paralytic effects. This passive transfer of immunity supplies immediate, short‑term protection until the patient’s own active immune response can develop in the bloodstream during the acute phase.

Side Effects

Igantet may be associated with adverse reactions following intramuscular administration.

Common Side Effects

  • Injection site pain: mild discomfort at the site of administration.
  • Redness or swelling: localized erythema around the injection.
  • Fever: transient low‑grade temperature elevation.
  • Headache: mild to moderate headache occurring shortly after dosing.
  • Nausea: occasional feeling of queasiness.
  • Malaise: general sense of fatigue or weakness.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Serum sickness‑like reaction: fever, rash, arthralgia occurring days after injection.
  • Severe allergic response: urticaria, bronchospasm, hypotension.
  • Hemolysis: destruction of red blood cells leading to anemia.
  • Aseptic meningitis: inflammation of meninges without infection.
  • Thrombophlebitis: inflammation of a vein at the injection site.

Precautions & Warnings

When using Igantet, several precautions should be observed to ensure safety and efficacy.

  • Assess tetanus immunization history: verify prior vaccination status before use.
  • Screen for hypersensitivity: avoid in patients with known IgG allergy.
  • Use with caution in immunocompromised patients: monitor for reduced efficacy.
  • Avoid concurrent administration with live vaccines: may interfere with immune response.
  • Observe for signs of anaphylaxis: have emergency equipment ready.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Igantet can interact with other medicines; awareness of major and moderate interactions helps manage risk.

Major Interactions (Avoid)

  • Concurrent use of other tetanus antitoxins: may cause excess antibody load.
  • Immunoglobulin products with different specificities: risk of immune complex formation.
  • Live attenuated vaccines administered within 4 weeks: may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Anticoagulants: injection may increase bleeding risk at site.
  • Corticosteroids: may diminish antibody activity.
  • Blood products: may interfere with immunoglobulin levels.

Frequently Asked Questions

Igantet is a human tetanus immunoglobulin indicated for passive immunization. It is used to provide immediate protection against tetanus in individuals with uncertain vaccination status, to treat patients who have developed tetanus infection, and to manage high‑risk wounds where active vaccination alone may be insufficient.

Human tetanus immunoglobulin supplies purified IgG antibodies that bind specifically to tetanus neurotoxin. By neutralizing the toxin, the antibodies prevent it from attaching to nerve cells and block its paralytic action, delivering short‑term protection until the patient’s own immune system can generate active antibodies.

The dose of Igantet is determined by the prescribing clinician based on the patient’s immunization history, the nature of the wound, and the severity of any existing tetanus infection. Typical adult regimens range from a single dose to multiple doses, but exact amounts are individualized and should follow local clinical guidelines.

The pregnancy safety category for Igantet is not established. It should be used during pregnancy or lactation only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should evaluate each case carefully and discuss potential risks with the patient.

To order Igantet, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and the necessary import documentation.

Igantet provides passive immunity by delivering ready‑made antibodies that act immediately, whereas the tetanus toxoid vaccine stimulates the body’s own immune system to produce antibodies over weeks. Igantet is used for urgent protection or treatment, while the vaccine is the standard for long‑term active immunization.

Igantet must be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking. If the product is to be transported, maintain the cold chain throughout the journey to preserve potency.

Igantet is given as an intramuscular injection, typically into the deltoid or gluteal muscle. The injection site should be cleaned with an antiseptic, and the dose is administered using a sterile needle and syringe according to the prescriber’s instructions.

The most serious adverse reactions include anaphylaxis, serum‑sickness‑like reactions, severe allergic responses, hemolysis, aseptic meningitis, and thrombophlebitis at the injection site. Patients should be monitored closely after administration, and any signs of severe allergy or systemic reaction require immediate medical attention.

Igantet should not be given to individuals with a known hypersensitivity to human immunoglobulins or any component of the formulation. Caution is also advised for patients with severe immunodeficiency, uncontrolled bleeding disorders, or those who have recently received other tetanus antitoxins, unless specifically directed by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.